|本期目录/Table of Contents|

[1]陈 辉,樊茹佳,丁继侠.宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义[J].天津医科大学学报,2019,25(05):510-513.
 CHEN Hui,FAN Ru-jia,DING Ji-xia.Expression and clinical significance of Foxm1 and ANGPTL4 protein in cervical cancer tissues[J].Journal of Tianjin Medical University,2019,25(05):510-513.
点击复制

宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25
期数:
2019年05期
页码:
510-513
栏目:
临床医学
出版日期:
2019-09-20

文章信息/Info

Title:
Expression and clinical significance of Foxm1 and ANGPTL4 protein in cervical cancer tissues
文章编号:
1006-8147(2019)05-0510-04
作者:
陈 辉1樊茹佳2丁继侠1
(1. 河南工业大学医院妇科,郑州450001;2.河南省人民医院妇产科,郑州 450003)
Author(s):
CHEN Hui1FAN Ru-jia2DING Ji-xia1
(1. Department of Obstetrics and Gynecology, Henan University of Technology Hospital, Zhengzhou 450001, China; 2. Department of Obstetrics and Gynecology, Henan People’s Hospital, Zhengzhou 450003, China)
关键词:
宫颈癌Foxm1ANGPTL4临床意义
Keywords:
cervical cancer Foxm1 ANGPTL4 clinical significance
分类号:
R737.33
DOI:
-
文献标志码:
A
摘要:
目的:探讨宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义。方法:选取2017年1月-2018年3月河南省人民医院保存的宫颈癌组织标本72例,同时选取正常宫颈组织标本35例作为对照组,采用免疫组化检测Foxm1、ANGPTL4蛋白表达水平。结果:宫颈癌组织Foxm1和ANGPTL4蛋白阳性表达率为63.89%和75.00%,明显高于对照组(P<0.05);FIGO分期Ⅱ期、肌层浸润≥1/2、中低分化宫颈癌Foxm1蛋白阳性表达率分别为89.47%、84.62%和79.07%,明显高于Ⅰ期、肌层浸润<1/2、高分化患者(P<0.05);有脉管浸润宫颈癌ANGPTL4蛋白阳性表达率为95.24%,明显高于无脉管浸润(P<0.05);Foxm1与ANGPTL4蛋白表达呈正相关(rs=0.301,P<0.05)。结论:宫颈癌组织中Foxm1、ANGPTL4蛋白呈高表达,在疾病发生发展中可能有重要作用。
Abstract:
Objective: To investigate the expression and clinical significance of Foxm1 and ANGPTL4 in cervical cancer. Methods:From January 2017 to March 2018, 72 specimens of cervical cancer and 35 specimens of normal cervical tissue were selected as controls; the expression of Foxm1 and ANGPTL4 protein was detected by immunohistochemical staining. Results: The positive rates of Foxm1 and ANGPTL4 protein in cervical cancer tissues were 63.89% and 75.00%, which were significantly higher than those in the control group(P< 0.05); The positive expression rates of Foxm1 protein in stage II, myometrial invasion ≥ 1/2, and moderately and poorly differentiated cervical cancer were 89.47%, 86.84% and 79.07% respectively, which were significantly higher than those in stage I, myometrial invasion <1/2 and well differentiated patients(P<0.05); The positive expression rate of ANGPTL4 protein in cervical carcinoma with vascular invasion was 95.24%, which was significantly higher than that without vascular invasion(P<0.05); We found a positive correlation between Foxm1 and ANGPTL4 protein expression(rs=0.301, P < 0.05). Conclusion: Foxm1 and ANGPTL4 proteins are highly expressed in cervical cancer tissues, and may play an important role in the development of diseases.

参考文献/References:

[1] 聂丹,刘玲,夏纪毅,等. 血管生成素样蛋白4(ANGPTL4)敲低抑制宫颈癌SiHa细胞增殖并促进其凋亡[J]. 细胞与分子免疫学杂志,2016,32(4):488
[2] 吴欣,黄健,刘畅,等. 1,25-二羟维生素D3对2型糖尿病肾病患者血管生成素样蛋白4水平的影响[J]. 实用医学杂志,2017, 33(13):2201
[3] 徐龙鑫,刘镜,张麟,等. 关岭黄牛ANGPTL4基因多态性与生长性状关联分析[J]. 江苏农业科学,2016,44(9):51
[4] 孙瑶,吕红彬,周琦,等. 血管生成素样蛋白4(ANGPTL4)在增生型糖尿病视网膜病变患者血清和玻璃体中的表达[J]. 眼科新进展,2017,37(1):49
[5] 李文浩,刘秀,李少斌,等. 藏绵羊ANGPTL4基因第3内含子、第6外显子多态性分析[J]. 江西农业大学学报,2017,39(3):443
[6] Kubo H,Kitajima Y,Kai K,et al. Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer[J]. Oncol Letters,2016,11(2):1026
[7] 陈凌燕,尹卫东,唐朝克. LPL和Angptl4在糖尿病性心脏病发生发展中作用的研究新进展[J]. 生理科学进展,2017,19(5):328
[8] Zhu X,Guo X,Wu S,et al. ANGPTL4 correlates with NSCLC progression and regulates epithelial-mesenchymal transition via ERK pathway[J]. Lung,2016,194(4):637
[9] 陈重九,范思邈,郑瑞茂. 血管生成素样蛋白-4在动脉粥样硬化过程中的双重作用[J]. 生理科学进展,2016,17(5):380
[10] Ren Z. The ANGPTL3-4-8 model,a molecular mechanism for triglyceride trafficking[J]. Open Biology,2016,6(4):150272
[11] 刘秀婵,白人骁. ANGPTL3与ANGPTL4在类风湿关节炎患者血清中的表达意义[J]. 中国实验诊断学,2016,20(10):1740
[12] Abid K,Trimeche T,Mili D,et al. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population[J]. Lip Health Dis,2016,15(1):63
[13] Dong D,Jia L,Zhou Y,et al. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma[J]. UrolOncol,2017,35(5):279
[14] Gomez P E,Liabotis-Fontugne A,Durand M,et al. ANGPTL4-79.tential biomarkere risk in Type 2 diabetic Tunisian population[J]. Lip Health Dis,2016,15(1):63
[15] 王立娟,刘晨,许元文. ANGPTL4对苯肾上腺素诱导的心肌纤维化的调控[J]. 实用医学杂志,2017,33(12):1939
[16] 吴翠霞,张艳红,葛小花,等. 高危型HPV感染与宫颈癌前病变与宫颈癌的相关性研究[J]. 中华医院感染学杂志,2016,26(11):2568
[17] 彭俊,黄勇. 90例年轻宫颈癌患者临床特征及术后复发和预后相关因素分析[J]. 实用妇产科杂志,2016,32(1):42
[18] 李双,李雄,张媛,等. 宫颈癌的手术-病理分期和评分系统的建立和验证[J]. 现代妇产科进展,2016,25(11):801
[19] 宋亮,谢思遐,战军,等. 652例早期宫颈癌患者临床病理特征分析及选择低危患者条件探讨[J]. 实用妇产科杂志,2016,32(2):126
[20] 陈晓露,张波,吴蓉宜. CK26、VEGF和p53蛋白表达对宫颈癌患者预后的预测价值研究[J]. 重庆医学,2016,45(8):1083

相似文献/References:

[1]李晶晶,赵卫东,王德华.72例宫颈癌术后并发症及卵巢功能分析[J].天津医科大学学报,2014,20(01):63.
[2]崔丽阳,岳天孚.高危型HPV持续感染的影响因素探讨[J].天津医科大学学报,2014,20(03):209.
 CUI Li-yang,YUE Tian-fu.Investigation on factors for persistent high-risk human papilloma virus infection[J].Journal of Tianjin Medical University,2014,20(05):209.
[3]孙 艳,齐 政,王德华,等.miR-186通过靶定CEA抑制宫颈癌细胞转移[J].天津医科大学学报,2016,22(04):288.
 SUN Yan,QI Zheng,WANG De-hua,et al.miR-186 inhibits cervical cancer migration by targetting CEA[J].Journal of Tianjin Medical University,2016,22(05):288.
[4]李 娜,李洪林,尹利荣.HPV E6/E7 mRNA与YAP在宫颈癌中的表达与相关性研究[J].天津医科大学学报,2018,24(04):307.
 LI Na,LI Hong-lin,YIN Li-rong.HPV E6/E7 mRNA and YAP expression and their correlation in cervical carcinoma[J].Journal of Tianjin Medical University,2018,24(05):307.
[5]曲首辉,鲍志敏,刘荣欣.TCT、活检病理在宫颈上皮瘤变及早期宫颈癌诊断中的价值分析[J].天津医科大学学报,2018,24(04):360.

备注/Memo

备注/Memo:
基金项目 2016年度河南省医学科技攻关计划项目(201602184)
作者简介 陈辉(1979-),女,主治医师,硕士,研究方向:妇产科;通信作者:樊茹佳,E-mail:fanrujia@126.com。
更新日期/Last Update: 2019-10-11